NCT04518852
- Conditions
- Adenocarcinoma, Antineoplastic Agents, Carcinoma, +13 more
- Locations
-
- Sichuan Cancer Hospital and Research Institute Chengdu, Sichuan, China
Clinical trial condition
Explore clinical trials studying Molecular Mechanisms of Pharmacological Action. Study availability and eligibility vary by location and protocol.
NCT04518852
NCT05321602
NCT04922593
NCT03572790
NCT03841292
NCT03403777
NCT03863366
NCT03107013